Dr. Michelle A. Sato, MD

Dr. Sato practices at The Endoscopy Center at Skypark - Torrance in Torrance, California.

Dr. Sato's NPI, 1225326580, was assigned on July 20, 2011. Dr. Sato graduated from New York Medical College in 2008. Dr. Sato holds California license A125720.

Dr. Sato's primary practice is The Endoscopy Center at Skypark - Torrance, at 23441 Madison St, Torrance, CA 90505 in Los Angeles County. The practice phone is (310) 375-6461.

Dr. Sato's primary practice is The Endoscopy Center at Skypark - Torrance in Torrance, California. Dmand AI also links Dr. Sato to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sato practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sato's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Sato is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Sato is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Sato treats.

CMS data shows 4,615 Medicare services from Dr. Sato across 17 procedure codes in 2024, for 1,026 Medicare patients. Medicare paid $302,002 for them.

CMS counts 1,026 Medicare patients who saw Dr. Sato in 2024. The largest group is 75 to 84, with 393 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sato's median patient age at 74, with 60% women.

In 2024, Dr. Sato wrote 4,225 Medicare Part D claims for 828 patients. 56% of them were for generic drugs. CMS names the drug for 4,101 of them, across 26 drugs with 11 or more claims each, at $432,758 in total drug cost. In 2023, CMS named 3,990 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sato for performance year 2024, reported as part of a group. Dr. Sato accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 69 procedures of cataract surgery by Dr. Sato, more than 69% of the clinicians it reports for that procedure.

CMS Open Payments shows 205 general payments to Dr. Sato from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Alcon Laboratories Inc paid the most, $2,052.

Dr. Sato graduated from New York Medical College in 2008.

Dr. Sato is in network with 23 carriers, including Aetna, Elevance and Humana. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.